title: In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply.
authors.affiliation: aDepartment of Paediatric Hematology, Immunology and Infectious Diseases, Emma Children's Hospital and Departement of Experimental Immunology, Academic Medical Centre, University of Amsterdam, Amsterdam bDepartment of Paediatrics, Amphia Hospital, Breda cDepartment of Internal Medicine dDepartment of Gynaecology and Obstetrics, Academic Medical Centre, University of Amsterdam eHIV Monitoring Foundation, Amsterdam fDepartment of Experimental Immunology, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands. *Henriette J. Scherpbier and Madeleine J. Bunders contributed equally to the writing of this article.
authors.forename: L
authors.initials: L
authors.lastname: Denneman
authors.forename: S
authors.initials: S
authors.lastname: Cohen
authors.forename: M H
authors.initials: MH
authors.lastname: Godfried
authors.forename: E
authors.initials: E
authors.lastname: van Leeuwen
authors.forename: J F
authors.initials: JF
authors.lastname: Nellen
authors.forename: T W
authors.initials: TW
authors.lastname: Kuijpers
authors.forename: D
authors.initials: D
authors.lastname: Pajkrt
authors.forename: A
authors.initials: A
authors.lastname: van de Plas
authors.forename: C
authors.initials: C
authors.lastname: Smit
authors.forename: A M
authors.initials: AM
authors.lastname: Weijsenfeld
authors.forename: Henriette J
authors.initials: HJ
authors.lastname: Scherpbier
authors.forename: Madeleine J
authors.initials: MJ
authors.lastname: Bunders
mesh_terms: D019380:Anti-HIV Agents; D005500:Follow-Up Studies; D015658:HIV Infections; D006801:Humans; D007223:Infant; D018445:Infectious Disease Transmission, Vertical; D011251:Pregnancy Complications, Infectious; D000068698:Tenofovir
chemical_list: D019380:Anti-HIV Agents; D000068698:Tenofovir